Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Palma JA. Neurology 2022;99:260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Palma JA. Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology 2022;99:260.
PMID: 35940896